
|Articles|January 23, 2018
What Should Specialty Pharmacists Know About the ReDOS Clinical Trial?
Tanios Bekaii-Saab, MD, FACP, Mayo Clinic Cancer Center, talks about key takeaways from the phase 2 ReDOS clinical trial for specialty pharmacists.
Advertisement
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Round-Up: Every Most Favored Nation Agreement With the Trump Administration
2
From the Pharmacy Counter to the Kitchen Cabinet: Helping Patients Choose Quality Supplements
3
Study Finds Persistent Gaps in Diagnoses for Depression and Chronic Conditions After COVID-19
4
Atebimetinib Signals a Potential Shift in First-Line Pancreatic Cancer Outcomes
5


























